Indivior Inc. v. Mylan Technologies Inc.

1:15-cv-01016

Overview

Case Number 1:15-cv-01016

Filing Date 2015-11-04

Status Terminated

Termination Date 2019-09-05

Court District Court, D. Delaware (ded)

Presiding Judge Richard G. Andrews

Nature of Suit 830 Patent

Jurisdiction Type Federal Question

Cause of Action 35:271 Patent Infringement

Jury Demand None

Parties

Defendant

Alvogen Pine Brook LLC

Represented By

7 Attorneys Listed

Steven H. Sklar

Email: ssklar@leydig.com

Nicole E. Kopinski

Email: nkopinski@leydig.com

J. Karl Gross

Email: kgross@leydig.com

Gregory C. Bays

Email: gbays@leydig.com

Elizabeth M. Crompton

Email: elizabethcrompton@parkerpoe.com

David M. Airan

Email: dairan@leydig.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311

Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Mylan N.V.

Represented By

2 Attorneys Listed

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Mylan Pharmaceuticals Inc.

Represented By

5 Attorneys Listed

Tung-On Kong

Email: tkong@wsgr.com

Elham F. Steiner

Email: esteiner@wsgr.com

David M. Hanna

Email: dhanna@proskauer.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Mylan Technologies Inc.

Represented By

3 Attorneys Listed

Nellie J. Amjadi

Email: namjadi@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Plaintiff

Aquestive Therapeutics, Inc.

Represented By

9 Attorneys Listed

Jamie Lucia

Email: jlucia@steptoe.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rachel M. Hofstatter

Email: rhofstatter@steptoe.com

James F. Hibey

Email: jhibey@steptoe.com

Cassandra A Adams

UNDELIVERABLE EMAIL 2/12/2019

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329

Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Indivior UK Limited

Represented By

9 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Katherine Harihar

Email: katherine.harihar@troutmansanders.com

Sujatha Vathyam

UNDELIVERABLE EMAIL 11/3/2020

Daniel Sharpe

Email: daniel.sharpe@troutman.com

Daniel A. Ladow

UNDELIVERABLE EMAIL 11/3/2020

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329

Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Indivior Inc.

Represented By

21 Attorneys Listed

Magnus J. Essunger

Email: magnus.essunger@troutman.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Timothy P. Heaton

UNDELIVERABLE EMAIL 6/1/20

Timothy C. Bickham

Email: tbickham@steptoe.com

Sujatha Vathyam

UNDELIVERABLE EMAIL 11/3/2020

R. Jason Fowler

Email: jfowler@cov.com

Puja Patel Lea

Email: puja.lea@troutman.com

Nicholas F. Lenning

Email: nicholas.lenning@klgates.com

Jeffrey H. Lerner

Email: jlerner@cov.com

Jeffrey B. Elikan

Email: jelikan@cov.com

James M. Bollinger

Email: james.bollinger@troutman.com

Daniel Sharpe

Email: daniel.sharpe@troutman.com

Daniel A. Ladow

UNDELIVERABLE EMAIL 11/3/2020

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329

Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Craig C. Crockett

Email: craig.crockett@troutmansanders.com

Charanjit Brahma

Email: cbrahma@beneschlaw.com

Bennet J. Moskowitz

Email: bennet.moskowitz@troutmansanders.com

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Andrew D. Regan

Email: andrew.regand@troutmansanders.com

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Richard G. Andrews

Patents Involved

3 Patents

There are 3 patents involved in this case.

Application Number	Patent Number	External Links
-	US8475832	Espacenet Google Patents
-	US8017150	Espacenet Google Patents
-	US8603514	Espacenet Google Patents

Docket Entries

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1821211.) - filed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 11/04/2015)

2015-11-04

Download

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1821211.) - filed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 11/04/2015)

2015-11-04

View

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1821211.) - filed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 11/04/2015)

2015-11-04

View

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1821211.) - filed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 11/04/2015)

2015-11-04

View

Indivior Inc. v. Mylan Technologies Inc.

Overview

Parties

Defendant

Alvogen Pine Brook LLC

Represented By

Mylan N.V.

Represented By

Mylan Pharmaceuticals Inc.

Represented By

Mylan Technologies Inc.

Represented By

Plaintiff

Aquestive Therapeutics, Inc.

Represented By

Indivior UK Limited

Represented By

Indivior Inc.

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 11/04/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/23/2015. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 3/23/2018. (dmp, ) (Entered: 11/04/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,475,832; 8,017,150; 8,603,514;. (dmp, ) (Entered: 11/04/2015)

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MonoSol Rx LLC. (dmp, ) (Entered: 11/04/2015)

SUMMONS Returned Executed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. Mylan Pharmaceuticals Inc. served on 11/4/2015, answer due 11/25/2015. (Bourke, Mary) (Entered: 11/05/2015)

Alias SUMMONS Returned Executed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. Mylan Technologies Inc. served on 11/5/2015, answer due 11/27/2015. (Bourke, Mary) (Entered: 11/05/2015)

MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Attachments: # 1 Proposed Order)(Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Attachments: # 1 Proposed Order)(Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

DECLARATION of Thomas W. Jenkins re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

DECLARATION of Frank Mullery re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

[SEALED] DECLARATION of John T. Hango re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

MOTION for Pro Hac Vice Appearance of Attorney Tung-On Kong, David M. Hanna and Elham Firouzi Steiner of Wilson Sonsini Goodrich and Rosati - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Palapura, Bindu) (Entered: 11/30/2015)

REDACTED VERSION of 10 Opening Brief in Support, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 12/2/2015 (nms). (Entered: 12/02/2015)

REDACTED VERSION of 13 Declaration of John T. Hango, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 12/2/2015 (nms). (Entered: 12/02/2015)

NOTICE of Appearance by Daniel Marcus Attaway on behalf of Indivior Inc., Indivior UK Limited, MonoSol Rx LLC (Attaway, Daniel) (Entered: 12/08/2015)

MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan; Jeffrey H. Lerner & Erica N. Andersen - filed by Indivior Inc., Indivior UK Limited. (Attaway, Daniel) (Entered: 12/08/2015)

MOTION for Pro Hac Vice Appearance of Attorney Daniel A. Ladow, James M. Bollinger, Timothy P. Heaton, J. Magnus Essunger, Sujatha Vathyam, Puja Patel Lea & Andrew D. Regan - filed by Indivior Inc., Indivior UK Limited. (Attaway, Daniel) (Entered: 12/11/2015)

Indivior Inc. v. Mylan Technologies Inc.

Overview

Parties

Defendant

Alvogen Pine Brook LLC Follow

Represented By

Mylan N.V. Follow

Represented By

Mylan Pharmaceuticals Inc. Follow

Represented By

Mylan Technologies Inc. Follow

Represented By

Plaintiff

Aquestive Therapeutics, Inc. Follow

Represented By

Indivior UK Limited Follow

Represented By

Indivior Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 11/04/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/23/2015. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 3/23/2018. (dmp, ) (Entered: 11/04/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,475,832; 8,017,150; 8,603,514;. (dmp, ) (Entered: 11/04/2015)

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MonoSol Rx LLC. (dmp, ) (Entered: 11/04/2015)

SUMMONS Returned Executed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. Mylan Pharmaceuticals Inc. served on 11/4/2015, answer due 11/25/2015. (Bourke, Mary) (Entered: 11/05/2015)

Alias SUMMONS Returned Executed by Indivior UK Limited, Indivior Inc., MonoSol Rx LLC. Mylan Technologies Inc. served on 11/5/2015, answer due 11/27/2015. (Bourke, Mary) (Entered: 11/05/2015)

MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Attachments: # 1 Proposed Order)(Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Attachments: # 1 Proposed Order)(Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

DECLARATION of Thomas W. Jenkins re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

DECLARATION of Frank Mullery re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

[SEALED] DECLARATION of John T. Hango re 9 MOTION to Dismiss for Lack of Jurisdiction, Improper Venue, and Failure to State a Claim, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 11/30/2015 (nms). (Entered: 11/25/2015)

MOTION for Pro Hac Vice Appearance of Attorney Tung-On Kong, David M. Hanna and Elham Firouzi Steiner of Wilson Sonsini Goodrich and Rosati - filed by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Palapura, Bindu) (Entered: 11/30/2015)

REDACTED VERSION of 10 Opening Brief in Support, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 12/2/2015 (nms). (Entered: 12/02/2015)

REDACTED VERSION of 13 Declaration of John T. Hango, by Mylan N.V., Mylan Pharmaceuticals Inc., Mylan Technologies Inc.. (Moore, David) Modified on 12/2/2015 (nms). (Entered: 12/02/2015)

NOTICE of Appearance by Daniel Marcus Attaway on behalf of Indivior Inc., Indivior UK Limited, MonoSol Rx LLC (Attaway, Daniel) (Entered: 12/08/2015)

MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan; Jeffrey H. Lerner & Erica N. Andersen - filed by Indivior Inc., Indivior UK Limited. (Attaway, Daniel) (Entered: 12/08/2015)

MOTION for Pro Hac Vice Appearance of Attorney Daniel A. Ladow, James M. Bollinger, Timothy P. Heaton, J. Magnus Essunger, Sujatha Vathyam, Puja Patel Lea & Andrew D. Regan - filed by Indivior Inc., Indivior UK Limited. (Attaway, Daniel) (Entered: 12/11/2015)

Track Case Updates

Alvogen Pine Brook LLC

Mylan N.V.

Mylan Pharmaceuticals Inc.

Mylan Technologies Inc.

Aquestive Therapeutics, Inc.

Indivior UK Limited

Indivior Inc.